Xtant Medical Holdings (XTNT) Net Margin (2016 - 2025)
Historic Net Margin for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to 3.93%.
- Xtant Medical Holdings' Net Margin rose 219200.0% to 3.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.32%, marking a year-over-year increase of 167600.0%. This contributed to the annual value of 14.03% for FY2024, which is 147500.0% down from last year.
- Latest data reveals that Xtant Medical Holdings reported Net Margin of 3.93% as of Q3 2025, which was up 219200.0% from 10.03% recorded in Q2 2025.
- Xtant Medical Holdings' 5-year Net Margin high stood at 36.9% for Q3 2023, and its period low was 17.98% during Q3 2024.
- In the last 5 years, Xtant Medical Holdings' Net Margin had a median value of 11.58% in 2023 and averaged 7.24%.
- Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 531700bps in 2023, then plummeted by -548800bps in 2024.
- Over the past 5 years, Xtant Medical Holdings' Net Margin (Quarter) stood at 17.02% in 2021, then grew by 15bps to 14.47% in 2022, then decreased by -6bps to 15.31% in 2023, then skyrocketed by 34bps to 10.04% in 2024, then soared by 139bps to 3.93% in 2025.
- Its Net Margin stands at 3.93% for Q3 2025, versus 10.03% for Q2 2025 and 0.18% for Q1 2025.